U
CPIX icon

UBS’s Cumberland Pharmaceuticals CPIX Stock Holding History

UBS’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$15K Sell
3,081
-1,900
-38% -$9.19K ﹤0.01% 8347
2014
Q2 		$23K Buy
4,981
+949
+24% +$4.24K ﹤0.01% 7888
2014
Q1 		$19K Sell
4,032
-383
-9% -$1.82K ﹤0.01% 8143
2013
Q4 		$22K Sell
4,415
-149
-3% -$727 ﹤0.01% 8027
2013
Q3 		$21K Sell
4,564
-9,308
-67% -$46.3K ﹤0.01% 7987
2013
Q2 		$71K Buy
+13,872
New +$69K ﹤0.01% 6309

Other funds holding CPIX

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.25B AUM 19.46% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

UBS's CPIX Position: Q3 2014 in Review

UBS reduced its Cumberland Pharmaceuticals (CPIX) stake by 38% in Q3 2014, selling an estimated $9.19K and leaving 3,081 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #8347.

UBS first reported a position in CPIX in Q2 2013 and has held it in 6 quarters since. The position peaked at $71K in Q2 2013. 45 funds tracked by Wall St. Rank hold CPIX as of Q3 2014.

  • UBS held 3,081 shares of Cumberland Pharmaceuticals worth $15K as of Q3 2014.
  • UBS sold 1,900 Cumberland Pharmaceuticals shares in Q3 2014, an estimated $9.19K.
  • Cumberland Pharmaceuticals made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8347 holding.
  • UBS first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
  • UBS's Cumberland Pharmaceuticals position peaked at $71K in Q2 2013.
  • 45 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.